The FIP Development Goals Report 2021: Setting goals for the decade ahead

 

Launched in January 2022, the FIP Development Goals Report 2021 “Setting goals for the decade ahead” provides a global status update on the goals one year on since their launch and serves as an anchor point that will facilitate the next decade’s roadmap aligned with the UN Agenda 2030.

Part 1 is a summary of how the FIP Development Goals will support pharmacy transformation by bringing together pharmaceutical practice, science, and workforce and education, in alignment with the global sustainable development agenda.  A summary of programmes of work delivered since the launch of the goals in September 2020 are outlined, with a focus on 2021, the first year of the goals and first year of the decade ahead.

In the second part of the report, global, regional and national needs and priorities are described. FIP’s regional engagement strategy 2021 provided opportunities not only to engage with our members but also to identify their needs using the FIP Development Goals as an assessment framework. These are presented in detail and feature the voices of our members everywhere.

The final Part 3 presents an overview of each of the FIP Development Goals, showcasing how FIP continues to support its members through our events, programmes of work, and lessons collated from members worldwide. In this section, we remind our members what each goal aims to achieve across its three elements, detail how FIP supports the implementation of the goal, provides lessons learnt from members across the world on how they are trying to progress priority goals in their country.

This publication captures the scope of work FIP has done in 2021, and the commitments we have made to our members. We stand by our commitment now and in the future to support our members to transform pharmacy with clear action, in solidarity with all.

Download the publication here.

Watch the report launch event here.

 

Report Bonus Features

 

The report includes an overview of our members’ needs collated through our engagement initiatives in 2021. These include one-on-one interviews we conducted with our members. These tailored interviews with member and observer organisations included the following questions:

Q1. “Do you have new initiatives around your selected priority development goals?”

Q2. “How well do you see the FIP Development Goals aligning with your organisation’s priorities and philosophy?”

Links to video responses can be found below, organized by region:

 

Africa

Redouane Soualmi, Chairperson of External Relations, Fédération Algérienne de Pharmacie (Algeria). Click here and here for responses to Q1 and Q2 respectively.

Samuel Ohuabunwa, President, Pharmaceutical Society of Nigeria (Nigeria). Click here and here  for responses to Q1 and Q2.

Mariet Eksteen, Professional Development and Support, Pharmaceutical Society of South Africa (South Africa). Click here for response to Q1.

 

Americas

Glen Doucet, CEO, Canadian Pharmacists Association (Canada). Click here and here for responses to Q1 and Q2.

Lidiette Fonseca González, Vice-President of the Board of Directors, Colegio de Farmacéuticos de Costa Rica (Costa Rica). Click here and here for responses to Q1 and Q2.

Douglas Scheckelhoff, Sr. Vice President & International Affairs, American Society of Health-System Pharmacists (USA). Click here for response to Q1.

Daniel Zlott, Senior Vice President, Education & Business, American Pharmacists Association (USA).  Click here and here for responses to Q1 and Q2.

Mariela Méndez, President, Uruguayan Association of Chemistry and Pharmacy (Uruguay). Click here and here for responses to Q1 and Q2.

 

Eastern Mediterranean

Mohamed Al-nuzili, President, Community Pharmacy Owner Syndicate (Yemen). Click here and here for responses to Q1 and Q2.

 

Europe

Safiye Çağansel, Treasurer, Cyprus Turkish Pharmacist Association (Cyprus). Click here and here for responses to Q1 and Q2.

Inga Lilý Gunnarsdóttir, President, Pharmaceutical Society of Iceland (Iceland). Click here for respose to Q1.

Mary Ann Sant Fournier, President, Malta Chamber of Pharmacists (Malta). Click here and here for responses to Q1 and Q2.

Ka Chun Cheung, Manager Medicine Information Center, The Royal Dutch Pharmacists Association (Netherlands). Click here for the response to Q1.

Jorge Batista, International affairs, Portuguese Pharmaceutical Society (Portugal). Click here and here for responses to Q1 and Q2.

Cristina Pavel, President, Ethica Independent Pharmacies Association (Romania). Click here for the response to Q1.

Jo Craig, Chairwoman, the Academy of Pharmaceutical Sciences and Linda Hakes, Independent consultant, the Academy of Pharmaceutical Sciences (UK). Click here and here for responses to Q1 and Q2.

 

South East Asia

Bhojraj Suresh, President, Indian Association of Colleges of Pharmacy (India). Click here and here for responses to Q1 and Q2.

 

Western Pacific

Joseph Nicolazzo, President, Australasian Pharmaceutical Science Association (Australia). Click here for the response to Q1.

Chris Freeman, National President, Pharmaceutical Society of Australia and Peter Guthrey, Senior Pharmacist, Strategic Policy & Advocacy, Pharmaceutical Society of Australia (Australia). Click here and here for responses to Q1 and Q2.

Jack Chen, Secretary General/International Affairs, Taiwan Society of Health-System Pharmacists (China Taiwan). Click here and here for responses to Q1 and Q2.

Ichiro Matsuoka, Pharmaceutical Society of Japan (Japan). Click here for the response to Q1.

Sang Hoon Joo, Vice Chair of International Affairs, the Korean Pharmaceutical Association (Korea). Click here and here for responses to Q1 and Q2.

Jack Shen Lim, Treasurer, Malaysian Pharmaceutical Society (Malaysia). Click here and here for responses to Q1 and Q2.

 

Disclaimer: FIP obtained consent to share these video segments from all involved members.